InvestSMART

Rhythm Biosciences Limited (ASX: RHY) - Announcements

- Current share price for RHY : $0.080

ASX company news and announcements for Rhythm Biosciences Limited (RHY) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Rhythm Biosciences Limited (RHY) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Rhythm Biosciences Limited (RHY), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Rhythm Biosciences Limited (RHY)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$28 Notice of Annual General Meeting/Proxy Form 20 Oct 2021 4:22PM $1.200 $0.080 fallen by 93.33%
$28 Rhythm Receives $2.4m R&D Tax Incentive 5 Oct 2021 9:05AM $1.185 $0.080 fallen by 93.25%
$28 Notice Required Under ASX Listing Rule 3.13.1 4 Oct 2021 3:55PM $1.220 $0.080 fallen by 93.44%
$28 Change in substantial holding 29 Sep 2021 4:55PM $1.220 $0.080 fallen by 93.44%
$28 Rhythm Completes Recruitment for Clinical Trial (Study 7) 22 Sep 2021 8:45AM $1.180 $0.080 fallen by 93.22%
$28 TGA Accepts Initial Regulatory Documentation 14 Sep 2021 9:57AM $1.050 $0.080 fallen by 92.38%
$28 Cleansing Notice 13 Sep 2021 4:38PM $1.050 $0.080 fallen by 92.38%
$28 Notification regarding unquoted securities - RHY 13 Sep 2021 4:32PM $1.050 $0.080 fallen by 92.38%
$28 Application for quotation of securities - RHY 13 Sep 2021 4:30PM $1.050 $0.080 fallen by 92.38%
$28 Change of Director's Interest Notice x 4 9 Sep 2021 6:15PM $1.000 $0.080 fallen by 92%
$28 Notification regarding unquoted securities - RHY 9 Sep 2021 8:51AM $1.070 $0.080 fallen by 92.52%
$28 Application for quotation of securities - RHY 9 Sep 2021 8:49AM $1.070 $0.080 fallen by 92.52%
$28 Proposed issue of securities - RHY 7 Sep 2021 1:13PM $1.220 $0.080 fallen by 93.44%
$28 Rhythm Completes Strongly Oversubscribed $4.3M Rights Issue 7 Sep 2021 11:31AM $1.175 $0.080 fallen by 93.19%
$28 Appendix 4G and Corporate Governance Statement 31 Aug 2021 5:20PM $0.925 $0.080 fallen by 91.35%
$28 Annual Report 31 Aug 2021 5:18PM $0.925 $0.080 fallen by 91.35%
$28 Appendix 4E 31 Aug 2021 5:16PM $0.925 $0.080 fallen by 91.35%
$28 No Extension to Rights Issue Offer Closing Date 31 Aug 2021 11:56AM $0.910 $0.080 fallen by 91.21%
$28 Initial TGA Regulatory Documentation Submitted 19 Aug 2021 9:16AM $0.900 $0.080 fallen by 91.11%
$28 Letter to ineligible shareholders 10 Aug 2021 9:44AM $0.970 $0.080 fallen by 91.75%
$28 Non Renounceable pro rata offer - Completion of despatch 10 Aug 2021 9:20AM $0.970 $0.080 fallen by 91.75%
$28 Cleansing Notice 4 Aug 2021 4:17PM $0.955 $0.080 fallen by 91.62%
$28 Application for quotation of securities - RHY 4 Aug 2021 4:15PM $0.955 $0.080 fallen by 91.62%
$28 Securities Trading Policy 30 Jul 2021 4:17PM $0.915 $0.080 fallen by 91.26%
$28 Update - Proposed issue of securities - RHY 30 Jul 2021 11:18AM $0.950 $0.080 fallen by 91.58%

451 - 475 of 645 results

Page 19 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.